Form 8 (DD) - Futura Medical
Roy Davis, a Non-Executive Director of Futura Medical PLC, has disclosed dealings in the company's relevant securities on September 25, 2026. Following these dealings, Mr. Davis holds interests in 2,540,295 ordinary shares, representing 0.17% of the company's relevant securities. No short positions or derivative dealings were disclosed. This disclosure was made on September 29, 2026, in accordance with Takeover Code rules.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
KEY INFORMATION
| (a) Full name of discloser: | Roy Davis | ||
| (d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) | Non-Executive Director | ||
| (e) Date dealing undertaken: | 25 September 2026 | ||
| 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE | |||
| Class of relevant security: | |||
| Interests | Short positions | ||
| Number | % | Number | % |
| (1) Relevant securities owned and/or controlled: | 2,540,295 | 0.17 | |
- Cash-settled derivatives:
- Stock-settled derivatives (including options) and agreements to purchase/sell:
| TOTAL: | 2,540,295 | 0.17 |
All interests and all short positions should be disclosed.
- Rights to subscribe for new securities (including directors’ and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
DEALINGS BY THE PERSON MAKING THE DISCLOSURE
The currency of all prices and other monetary amounts should be stated.
Purchases and sales
| Class of relevant security | Purchase/sale | Number of securities | Price per unit |
- Cash-settled derivative transactions
- Stock-settled derivative transactions (including options)
- Writing, selling, purchasing or varying
- Exercise
- Other dealings (including subscribing for new securities)
- OTHER INFORMATION
- Indemnity and other dealing arrangements
- Agreements, arrangements or understandings relating to options or derivatives
- Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | NO |
| Supplemental Form 8 (SBL) | NO |
| Date of disclosure: | 29 September 2026 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.